Stephan D Parent

Inventor

Add to Portfolio

Stats

Details

Work History

Patent OwnerApplications FiledYear
SALIX PHARMACEUTICALS, LTD.
2
5
1
2
1
2011
2012
2013
2014
2015
AMBIT BIOSCIENCES
2
2
2008
2014
AMBIT BIOSCIENCES CORPORATION
1
2008
PHOTOCURE ASA
2
2013
TELIK, INC.
3
2011
VIRGINIA COMMONWEALTH UNIVERSITY
1
2005
JEFFERIES FINANCE LLC, AS COLLATERAL AGENT AND GRANTEE
2
2013
FERROKIN BIOSCIENCES, INC.
2
6
1
2009
2011
2013
TAKEDA PHARMACEUTICALS U.S.A., INC.
2
2
2009
2011
GLOBAL BLOOD THERAPEUTICS, INC.
1
1
2015
2016
SUN PHARMACEUTICAL INDUSTRIES, INC.
2
2009
REATA PHARMACEUTICALS, INC.
2
2
2
2008
2011
2012
KALYPSYS, INC.
2
2006
MABVAX THERAPEUTICS HOLDINGS, INC.
1
2011
HARKNESS PHARMACEUTICALS, INC.
1
2006
IL-YANG PHARM. CO., LTD
5
4
2007
2010

Inventor Addresses

AddressDuration
San Carlos, CA, USOct 22, 15 - Oct 22, 15
San Diego, CAApr 26, 07 - Apr 26, 07
South San Francisco, CA, USSep 20, 16 - Jan 30, 25
W. Lafayette, IN, USFeb 19, 09 - Jan 21, 14
WEST LAFAYETTE, IN, USMar 07, 24 - Mar 07, 24
West LAfayette, IN, USDec 26, 23 - Dec 26, 23
West Lafayette, INJun 28, 07 - Aug 21, 08
West Lafayette, IN, USMay 21, 09 - Mar 18, 25

Technology Profile

Technology Matters
A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1
A61K: PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 43
A61P: THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 26

See more…

Patents / Publication

Patents / Publication #Year of Publication / IssuedTitleCitations
122524862025Solid state forms0
2025/0073,2442025CRYSTALLINE FORMS OF PENTAAZA MACROCYCLIC RING COMPLEX0
2025/0032,4712025Crystalline Polymorphs of the Free Base of 2-Hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde0
2024/0300,9882024CRYSTALLINE FORMS OF PENTAAZA MACROCYCLIC RING COMPLEX0
2024/0300,8972024CRYSTALLINE FORMS AND SALT FORMS OF A KINASE INHIBITOR0

See more…


We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
> Upgrade to our Level for up to -1 portfolios!.